5th Circ. Weighs 'Very Complex' Chemo Hair Loss Dispute

By Catherine Marfin · March 6, 2024, 8:00 PM EST

The Fifth Circuit is weighing whether two drug manufacturers had an obligation to expedite changing the label on their chemotherapy medications to warn of permanent hair loss in a case one...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Case Information

Case Title

Hickey v. Hospira

Case Number

Court

Appellate - 5th Circuit

Nature of Suit

4367 Torts

Date Filed

May 16, 2023

Recent Articles By Catherine

November 08, 2024
3rd Texas Doc Sued For Providing Kids Gender-Affirming Care
October 16, 2024
Houston Pharma Exec Found Guilty In $160M Health Fraud
October 02, 2024
Ex-PBM Worker Says He Bribed Co-Workers In $160M Fraud
October 01, 2024
Doctors Were 'Bamboozled' By $160M Health Fraud, Jury Told
September 26, 2024
Dallas VA Center Overpaid $3.7M For Wheelchair Services
September 05, 2024
Referral Model Means No Tax Exemption For Texas Health Co.
September 05, 2024
PE Firm Argues Tossing of FTC Case Also Ends Workers' Suit
May 30, 2024
Ozempic Maker Says Texas Pharmacy Selling Knockoff Drug
May 20, 2024
Texas Atty Chided For 'Crappy Strategy' Of Ducking Subpoena
May 10, 2024
Texas Justices Limit Damages In Unwanted Pregnancy Case